Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.77 |
| ▸ | THRB | P10828 | 1/20 | 0.77 |
| ▸ | HTT | P42858 | 1/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.77 |
| ▸ | MAPT | P10636 | 1/20 | 0.77 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.55 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.51 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.51 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.51 |
| ▸ | MGLL | Q99685 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1627567 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL6554473 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL11594173 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL11593906 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL965023 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL2123908 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL15972698 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL381638 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL965021 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL1627566 | 1.00 | MEN1 (0.77) | MEN1THRBHTTKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12508218-B2 | Coating compositions | COTY INC. (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250152487-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | COTY INC. | 2025-05-15 | — | — | US | disclosed |
| US-20250127707-A1 | FRAGRANCE FORMULATION | COTY INC. | 2025-04-24 | — | — | US | disclosed |
| US-20250127694-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | COTY INC. | 2025-04-24 | — | — | US | disclosed |
| US-20250032371-A1 | ETHANOL-FREE FRAGRANCE CHASSIS | COTY INC. | 2025-01-30 | — | — | US | disclosed |
| US-12178896-B2 | Fragrance compositions and uses thereof | COTY INC. (US) | 2024-12-31 | — | — | US | disclosed |
| US-20230285261-A1 | FRAGRANCE COMPOSITION COMPRISING A FRAGRANCE COMPONET AND A NON-ODOROUS FRAGRANCE MODULATOR | JPMORGAN CHASE BANK, N.A. | 2023-09-14 | — | — | US | disclosed |
| EP-3141239-B1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | PROCTER & GAMBLE (US) | 2023-05-10 | — | — | EP | disclosed |
| US-20220304914-A1 | COATING COMPOSITIONS | JPMORGAN CHASE BANK, N.A. | 2022-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220304914-A1 | COATING COMPOSITIONS | OR10J3, OR51E2, TAS2R20 | MEN1 3869/4885THRB 3352/4885HTT 3498/4885 |
| US-12178896-B2 | Fragrance compositions and uses thereof | FHIT, ALG3, FEM1B | MEN1 2579/4885THRB 3384/4885HTT 2320/4885 |
| US-20250032371-A1 | ETHANOL-FREE FRAGRANCE CHASSIS | OR51E2, FDFT1, ELANE | MEN1 1265/4885THRB 3739/4885HTT 2680/4885 |
| US-20250127694-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | TRPA1, TRPV1, NAA40 | MEN1 1906/4885THRB 4562/4885HTT 3325/4885 |
| US-20250127707-A1 | FRAGRANCE FORMULATION | PUF60, POLM, ADH5 | MEN1 3678/4885THRB 3530/4885HTT 4471/4885 |
| US-20230285261-A1 | FRAGRANCE COMPOSITION COMPRISING A FRAGRANCE COMPONET AND A NON-ODOROUS FRAGRANCE MODULATOR | OR51E2, TRPA1, FAM120A | MEN1 3300/4885THRB 3729/4885HTT 3381/4885 |
| US-12508218-B2 | Coating compositions | TAS2R40, TAS2R20, TAS2R10 | MEN1 4739/4885THRB 3077/4885HTT 4059/4885 |
| US-20250152487-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | FHIT, ALG3, FEM1B | MEN1 2579/4885THRB 3384/4885HTT 2320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.